[11] [12] Hypoglycaemia : Particularly relevant if retatrutide is used alongside insulin or sulphonylureas
And, if you live in Los Angeles (or any major metropolitan city, honestly), seemingly half of everyone you know has or is currently taking one of these medications for their weight loss-boosting effectseven if they swear their leaner frame is exclusively due to drinking more water and doing pilates. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) were initially developed and approved to treat type 2 diabetes and obesity by helping to regulate blood glucose levels, mimicking the effects of GLP-1, a naturally occurring hormone in the body that regulates digestion, appetite, and blood sugar
Across TRIUMPH-1 and TRANSCEND-T2D-1, retatrutide delivered substantial weight loss, meaningful A1C reduction, and improvements in knee osteoarthritis pain and moderate-to-severe obstructive sleep apnea, a breadth and magnitude of outcomes thats striking to see with a single therapy, says Kenneth Custer, PhD, executive vice president and president, Lilly Cardiometabolic Health, in a release
This is a metabolic pathway that neither GLP-1 nor GIP activation can access with the same potency
Common dosing considerations Take as directed on the label, ideally with food if tolerated
